Many of the risk factor associations vary by mutation type (i.e., BRCA1 versus BRCA2); however, whether this is attributed to the smaller numbers of BRCA2 mutation carriers included in most of the analyses or is a true biologic phenomenon given the differing risk profiles and pathologic features of the cancers depending on the mutated gene is unclear. The gene discussed is BRCA2; the disease is cancer.